ALNY Related Analyst Ratings
-
Roth Capital Downgrades Alnylam Pharmaceuticals (ALNY) to Hold. Price Target Cut
-
Leerink Swann Upgrades Alnylam Pharmaceuticals (ALNY) to Market Perform; Good Progress Demonstrated
-
Roth Capital Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Buy
-
Jefferies & Co Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Buy
-
Needham & Co Upgrades Alnylam Pharmaceuticals (ALNY) to Hold Based on Valuation and Pipeline Progress
-
Thomas Weisel Initiates Coverage on Alnylam Pharm (ALNY) with a Marketweight
-
Thomas Weisel Starts Alnylam Pharmaceuticals (ALNY) at Market Weight
-
Leerink Swann Starts Alnylam Pharmaceuticals (ALNY) at Underperform
-
Needham & Co Downgrades Alnylam (ALNY) to Underperform
-
Cantor Fitzgerald Raises Price Target on Alnylam Pharmaceuticals (ALNY)
-
Piper Jaffray & Co. Downgrades Alnylam Pharmaceuticals (ALNY) to Market Perform
-
Cantor Fitzgerald upgrades Alnylam Pharmaceuticals (ALNY) to Buy
-
Needham Downgrades Alnylam Pharmaceuticals (ALNY) to Hold
-
Piper Jaffray raises their price target on Alnylam Pharmaceuticals (ALNY) to $30
-
Piper Jaffray Said ISIS Pharma (ISIS) To Get Royalty Payments from Alnylam/Roche deal
-
CE Unterberg Towbin initiates coverage on Rosetta Genomics (ROSG) at Buy
-
Needham Sets New $26 Price Target on Alnylam Pharmaceuticals (ALNY)
-
Bear Stearns downgrades Alnylam (ALNY) to Peer Perform
-
Needham Comments on Other Stocks in RNAi Following Merck's Deal to Buy Sirna Therapeutics
-
Bear Stearns Starts Alnylam Pharmaceuticals, Inc. (ALNY) at Outperform
-
Matrix USA Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Strong Sell, Cantor Starts Coverage with Hold
-
Maxim Group Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with a Buy
-
House and Senate Negotiators agreed on $2.3B Avian Flu Funding - Analyst
-
Caris & Co Initiates Coverage on Alnylam Pharmaceuticals (ALNY) with an Above Average
-
Needham Raises its Price Target on Alnylam Pharma (ALNY)
-
Morgan Stanley Starts ALNY at Overweight
-
Needham Starts ALNY at Buy
-
Banc of America Starts ALNY at Buy
-
ThinkEquity downgrades ALNY to Accumulate
-
ALNY upped to Buy at Banc of America; $9.50 price tgt
Back to ALNY Stock Lookup
